Sysmex Corporation (SSMXY)
OTCMKTS
· Delayed Price · Currency is USD
16.69
-0.24 (-1.42%)
May 19, 2025, 3:50 PM EDT
Sysmex Revenue
In the fiscal year ending March 31, 2025, Sysmex had annual revenue of 508.64B JPY with 10.21% growth. Sysmex had revenue of 141.78B in the quarter ending March 31, 2025, with 5.03% growth.
Revenue
508.64B JPY
Revenue Growth
+10.21%
P/S Ratio
3.06
Revenue / Employee
50.65M JPY
Employees
10,042
Market Cap
10.38B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 508.64B | 47.13B | 10.21% |
| Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
| Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
| Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
| Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Sysmex News
- 4 days ago - Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B - Seeking Alpha
- 6 months ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha